Mimedx Group, Inc. (MDXG) SEC Filing 10-K Annual report for the fiscal year ending Thursday, December 31, 2015

Home SEC Filings Mimedx Group, Inc. (MDXG) 10-K Annual Report Mon Feb 29 2016



Exhibit 99.1
PRESS RELEASE CONTACT:
MICHAEL SENKEN
PHONE: (770) 651-9100


MiMedx Announces 2015 Record Results
 

Company Records Revenue of $187.3 Million,
Net Income of $29.4 million and EPS of $0.28 (Basic) and $0.26 (Diluted)


Marietta, Georgia, February 23, 2016, (PR Newswire) -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic membrane and other birth tissues, human skin and bone, and patent-protected processes and proprietary platforms to develop and market advanced products and therapies, announced today its record results for the full year and fourth quarter ended December 31, 2015.

Full Year 2015 Highlights are:
•
4th consecutive year of meeting or exceeding revenue guidance
•
Revenue of $187.3 million increased by 58% over 2014
•
Revenue nears upper end of MiMedx guidance range
•
Gross margin of 89% remains unchanged from its record level in 2014
•
Wound Care sales grew by more than 50% in 2015
•
Surgical, Sports Medicine & Orthopedics revenue grew more than 85% in 2015
•
Adjusted EBITDA* of $44 million represents a 113% improvement over 2014
•
Net income of $29.4 million represents a 373% improvement over 2014

Fourth Quarter 2015 Highlights are:
•
17th consecutive quarter of meeting or exceeding revenue guidance
•
Revenue of $51.8 million increased by 31% over Q4 2014
•
Revenue in upper range of MiMedx Q4 guidance
•
Gross margin of 90%
•
16th consecutive quarter of positive Adjusted EBITDA*
•
Adjusted EBITDA* of $12.9 million represents a 51% improvement over Q4 2014
•
Net income of $13.4 million represents a 249% improvement over Q4 2014

Results for Full Year and Fourth Quarter Ended December 31, 2015
For the year ended December 31, 2015, the Company recorded record revenue of $187.3 million, a $69.1 million or 58% increase over 2014 revenue of $118.2 million. The Company’s gross margin for the year ended December 31, 2015, was 89%, which was equal to the gross margin in the same period of 2014 in spite of market price decreases. Adjusted EBITDA* for the year ended December 31, 2015, was $44 million, a $23.3 million or 113% improvement, as compared to Adjusted EBITDA* of $20.7 million for the year ended December 31, 2014. Net Income for the year ended December 31, 2015, was $29.4 million, or $0.26 per diluted common share, a $23.2 million or 373% improvement, as compared to Net Income of $6.2 million, or $0.05 per diluted common share, in the same period of 2014.

The Company recorded record revenue for the fourth quarter of 2015 of $51.8 million, a $12.3 million or 31% increase over 2014 fourth quarter revenue of $39.6 million. The Company’s gross margin for the quarter ended December 31, 2015, was 90%, equal to the gross margin in the fourth quarter of 2014. Adjusted EBITDA* for the quarter ended December 31, 2015, was $12.9 million, a $4.4 million or 51% improvement, as compared to Adjusted EBITDA* of


The following information was filed by Mimedx Group, Inc. (MDXG) on Tuesday, February 23, 2016 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Mimedx Group, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Mimedx Group, Inc..

Continue

Rating

Learn More
Filter by Sentiment:
All
Positive
Negative
Filter by Category:
All
Revenue
Financial
Legal
M & A
Other
Filter by Subcategory:
All
Product
Shares
Expense
Debt
Earnings
Income
Other
Inside Mimedx Group, Inc.'s 10-K Annual Report:

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

SEC Filing Financial Summary

Microsoft Excel Excel Download

Loading SEC Filing Financial Summary...

Material Contracts, Statements, Certifications & more

Mimedx Group, Inc. provided additional information to their SEC Filing as exhibits

SEC Filing Exhibit

Adobe PDF PDF Download

Loading SEC Filing Exhibit...

Ticker: MDXG
CIK: 1376339
Form Type: 10-K Annual Report
Accession Number: 0001376339-16-000138
Submitted to the SEC: Mon Feb 29 2016 4:25:00 PM EST
Accepted by the SEC: Mon Feb 29 2016
Period: Thursday, December 31, 2015
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Insider Transactions
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/mdxg/0001376339-16-000138.htm

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account